09:46 AM EST - Sernova Corp. : Announced the presentation of new positive interim data from the ongoing Phase I/II clinical trial evaluating the safety, tolerability, and efficacy of the Sernova Cell Pouch Transplant System containing donor islets in people living with type 1 diabetes. Sernova Corp.
shares T.SVA are trading up $0.02 at $0.32.
